MedTrace Logo

Consensus Statements on Definition, Components and Grading of Postoperative Pulmonary Complications

NCT06916598 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-09-18

No results posted yet for this study

Summary

An international team of experts is working on a project called PrECiSIOn to develop a clear, consistent definition of PPCs. The goals of this study are to:

* Define postoperative pulmonary complications in a way that makes sense for patients, families, and healthcare providers.
* Rank complications by severity so doctors can focus on the most serious ones first.
* Decide how and when to monitor patients after surgery to catch problems early.

Conditions

  • Postoperative Pulmonary Complications

Interventions

OTHER

Delphi study

This Delphi study involves multiple iterative rounds until a stable consensus or dissensus is reached on all the statements.

OTHER

Structured Interview

Structured interviews will be conducted by members of the steering committee and an independent qualitative research expert. A pilot-tested case vignette along with a Likert scale-based questionnaire, will be employed to gather insights regarding the impact and severity of PPCs. The impact of the individual components of PPCs will be evaluated on a 7-point Global Rate of Change (GRC) scale (from "very much worse" to very much better") to calculate the minimal clinical important difference. Patient care representatives will be engaged in anonymous voting on the questionnaire. PPCs' rankings and key themes synthesised from the interviews will be shared with the panel in the second Delphi round, facilitating the integration of patient perspectives into the consensus process.

Sponsors & Collaborators

  • University of Wolverhampton

    collaborator OTHER

  • The Royal Wolverhampton Hospitals NHS Trust

    collaborator OTHER_GOV

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Marcus Schultz, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-08
Primary Completion
2025-12-30
Completion
2026-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06916598 on ClinicalTrials.gov